Journal article

Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduceBRCA1/2breast cancer risk

Laura E Forrest, Rowan Forbes Shepherd, Mary-Anne Young, Louise A Keogh, Paul A James

PSYCHO-ONCOLOGY | WILEY | Published : 2020


OBJECTIVE: Tamoxifen has been demonstrated to reduce breast cancer risk in high-risk, premenopausal women. Yet, very few young women with hereditary breast and ovarian cancer syndrome in Australia use tamoxifen, despite this being a less-invasive option compared to risk-reducing mastectomy. This study aims to examine young women's decision-making about and experience of taking tamoxifen to reduce their breast cancer risk. METHODS: Young women with a BRCA1/2 mutation participated in semi-structured qualitative interviews, recruited mainly from a metropolitan clinical genetics service. Data were analysed using an inductive, team-based approach to thematic analysis. RESULTS: Forty interviews wi..

View full abstract